Advisorshares Vice Etf Stock News

Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial''s U.S. life insurance subsidiaries… The post GENWORTH FINANCIAL INC – 10-K – Management''s Discussion and Analysis of Financial Condition and Results of Operations appeared first on InsuranceNewsNet .

Donald Smith & Co. released this week its fourth-quarter portfolio, revealing that its top trades included boosts to its holdings of Textainer Group Holdings Ltd. ( TGH , Financial), Kinross Gold Corp

Enact Holdings, Inc.'s (ACT) CEO Rohit Gupta on Q4 2021 Results - Earnings Call Transcript

Enact Holdings Inc (ACT) shares closed today at 1.6% below its 52 week high of $22.71, giving the company a market cap of $3B. The stock is currently up 8.1% year-to-date, up 15.2% over the past 12 months, and up 15.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 39.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -963.4% The company's stock price performance over the past 12 months beats the peer average by -883.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Enact Holdings Inc (ACT) shares closed today at 1.6% below its 52 week high of $22.71, giving the company a market cap of $3B. The stock is currently up 8.1% year-to-date, up 15.2% over the past 12 months, and up 15.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 39.3% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -963.4% The company's stock price performance over the past 12 months beats the peer average by -827.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Enact Holdings Inc (ACT) shares closed today at 1.9% below its 52 week high of $22.71, giving the company a market cap of $3B. The stock is currently up 8.2% year-to-date, up 15.3% over the past 12 months, and up 15.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 rose 0.6%. Trading Activity Trading volume this week was 21.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -5238.0% The company's stock price performance over the past 12 months beats the peer average by -655.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Enact Holdings Inc (ACT) shares closed today at 1.5% below its 52 week high of $22.71, giving the company a market cap of $3B. The stock is currently up 6.0% year-to-date, up 13.1% over the past 12 months, and up 13.1% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 42.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1566.4% The company's stock price performance over the past 12 months beats the peer average by -566.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors

DUBLIN , Jan. 12, 2022 /PRNewswire/ -- The "Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021" report has been added to ResearchAndMarkets.com''s offering. The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014- 2021 report provides comprehensive access to available deals and contract documents for over 2,900 clinical stage deals. The report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals and provides details of the latest clinical agreements announced in the healthcare sector. Understanding the flexibility of a prospective partner''s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

Here is how Enact Holdings, Inc. (ACT) and AllianceBernstein (AB) have performed compared to their sector so far this year.

RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its fourth quarter earnings release after the market closes on February 1, 202

New Jersey, United States,- Verified Market Research has recently published a research report titled, Diabetic Retinopathy Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to formulate

The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Quinine Sulphate market. It includes Porters Five Forces and PESTLE

Market Overview: A breast implant, also called an augmentation mammoplasty, is a prosthetic device used to alter the shape, size, and tone of a woman''s breast. This procedure involves the insertion of artificial implants into the breast to improve upon a